Human Genetics

, Volume 82, Issue 4, pp 313–316 | Cite as

Disomic homozygosity in 21-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome

  • Kyohko Abe
  • Tadashi Kajii
  • Norio Niikawa
Original Investigations


Nine patients with transient myeloproliferative syndrome (TMS) with or without Down syndrome (DS) phenotype were studied cytogenetically, particularly with regard to the origin of trisomy 21. Of six DS patients, five had standard trisomy 21 and one a mosaic consisting of 21-tetrasomic, trisomic and disomic cell lines. The other three non-DS patients were mosaics with both 21-trisomic and-disomic cell lines. In all nine patients, the leukemoid cells in TMS stage were largely or exclusively composed of trisomy or tetrasomy 21, an indiction that the additional chromosome(s) 21 plays an important role in the occurrence of TMS. Sequential Q-and R-banding analysis of heteromorphisms demonstrated that all these patients had a duplication of a chromosome 21, as revealed by an “aab” pattern, regardless of DS or normal phenotype or parental origin of the extra chromosome 21. Irrespective of the possibility of recombination, the “aa” chromosomes are homozygous, i.e. show disomic homozygosity: this may in turn result in the duplication of a gene that controls the proliferation of the myelogenous cells, thereby leading to TMS.


Internal Medicine Metabolic Disease Down Syndrome Parental Origin Normal Phenotype 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atkin NB, Baker MC (1988) Small metacentric marker chromosomes, particularly isochromosomes, in cancer Hum Genet 79: 96–102Google Scholar
  2. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British cooperative group. Ann Intern Med 103:460–462Google Scholar
  3. Human Gene Mapping 9 (1987) 9th International Workshop on Human Gene Mapping. Cytogenet Cell Genet 46:1-762Google Scholar
  4. Juberg RC, Mowrey PN (1983) Origin of nondisjunction in trisomy 21 syndrome: all studies compiled, parental age analysis, and international comparisons. Am J Med Genet 16:111–116Google Scholar
  5. Lampkin BC, Bove KE, Peipon JJ, Arivastava AK, Price JK, Jones MM (1985) Spontaneous remission of presumed congenital acute nonlymphoblastic leukemia (ANLL) in a karyotypically normal neonate. Am J Pediatr Hematol Oncol 7:346–351Google Scholar
  6. Lilleyman JS (1980) Congenital monocytic leukemia. Clin Lab Haematol 2:243–245Google Scholar
  7. Morgan R, Hecht F, Cleary ML, Sklar J, Link MP (1985) Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood 66:1466–1468Google Scholar
  8. Niikawa N, Kajii T (1984) The origin of mosaic Down syndrome: four cases with chromosome markers: Am J Hum Genet 36:123–130Google Scholar
  9. Rogers PCJ, Thomas JW, Kalousek DK, Baker MA (1983) Neonate with Down's syndrome and transient congenital leukemia. In vitro studies. Am J Pediatr Hematol Oncol 5:59–64Google Scholar
  10. Seibel NL, Sommer A, Miser J (1984) Transient neonatal leukemoid reactions in mosaic trisomy 21 J Pediatr 104:251–254Google Scholar
  11. Stewart GD, Hassold TJ, Berg A, Watkins P, Tanzi R Kurnit DM (1988) Trisomy 21 (Down syndrome): studying nondisjunction and meiotic recombination by using cytogenetic and molecular polymorphisms that span chromosome 21. Am J Hum Genet 42: 227–236Google Scholar
  12. Van Eys J, Flexner JM (1969) Transient spontaneous remission in a case of untreated congenital leukemia. Am J Dis Child 118:507–514Google Scholar
  13. Zipursky A, Peeters M, Poon A (1987) Megakaryoblastic leukemia and Down's syndrome — a review. In: McCoy EE, Epstein CJ (eds) Oncology and immunology of Down syndrome. (Progress in clinical and biological research) Liss, New York, pp 33–56Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • Kyohko Abe
    • 1
    • 2
  • Tadashi Kajii
    • 3
  • Norio Niikawa
    • 1
  1. 1.Department of Human GeneticsNagasaki University School of MedicineNagasakiJapan
  2. 2.Cytogenetics Research DepartmentKyushu Medical ScienceFukuokaJapan
  3. 3.Department of PediatricsYamaguchi University School of MedicineUbeJapan

Personalised recommendations